Advances in predicting acute GVHD

Research output: Contribution to journalReview articlepeer-review

80 Scopus citations


Acute graft-versus-host disease (GVHD) is a leading cause of non-relapse mortality following allogeneic haematopoietic cell transplantation. Attempts to improve treatment response in clinically-established GVHD have not improved overall survival, often due to the increased risk of infectious complications. Alternative approaches to decrease GVHD-related morbidity and mortality have focused on the ability to predict GVHD prior to clinical manifestation in an effort to provide an opportunity to abort GVHD development, and to gain new insights into GVHD pathophysiology. This review outlines the research efforts to date that have identified clinical and laboratory-based factors that are predictive of acute GVHD and describes future directions in developing algorithms that will improve the ability to predict the development of clinically relevant GVHD.

Original languageEnglish
Pages (from-to)288-302
Number of pages15
JournalBritish Journal of Haematology
Issue number3
StatePublished - Feb 2013
Externally publishedYes


  • Biomarkers
  • Bone marrow transplant
  • Bone marrow transplant immunology
  • Graft-versus-host disease
  • Prediction


Dive into the research topics of 'Advances in predicting acute GVHD'. Together they form a unique fingerprint.

Cite this